NCT03249519Recruiting
Radiation Therapy or Chemoradiation, Interstitial Brachytherapy in Combination With Hyperthermia in Advanced Cervical Cancer
Multimodal Therapy of Advanced Cervical Cancer With Radiotherapy or Chemoradiation, Interstitial Brachytherapy in Combination With Hyperthermia
Source: ClinicalTrials.gov · Last updated 15 Aug 2017 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
The combination of radiation therapy or chemoradiation with Interstitial brachytherapy for advanced cervical cancer (pN+, FIGO-Stage II B - IV A is standard of therapy. The radio- and chemosensitive effect of an additional hyperthermia might improve the clinical outcome.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 999 (estimated)
- First submitted
- 10 Aug 2017
- Start date
- 1 Aug 2017
- Primary completion date
- 31 Dec 2094
- Lead sponsor
- University of Erlangen-Nürnberg Medical School
- Diseases
- Cervical cancer
- NCT number
- NCT03249519
What you commit to
- Study type: Interventional
- Planned participants: 999
- From 1 Aug 2017 to the primary completion date, 31 Dec 2094
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Metal implants (length \> 2cm or dense clusters of marker clips in the pelvis)
- Patients not willing to use effective contraception during and up to 6 months after therapy
Other illness
- Pre-existing uncontrolled cardiac disease, signs of cardiac failure, or rhythm disturbances requiring therapy
- Cardiac Pacemaker
- Myocardial infarction within the past 12 months
- Congestive heart failure
- New York Heart Association (NYHA) class III or IV heart disease
- Disease that would preclude chemoradiation or deep regional hyperthermia
- Active or therapy-resistent bladder infections
- Pre-existing or concommitant immunodeficiency Syndrome
Other
- Complete bundle branch block
- Pregnant or lactating women
Who the study is looking for
- Histological confirmed carcinoma of the Cervix
- FIGO-Stage IIB-IVA; earlier stages when inoperable or according to patient's wish
- clinical M0; except: involvement of para-aortic lymph nodes
- Age ≥ 18 years
- ECOG ≤ 2
- Informed consent of the patient
Age in the registry: 18 years to - · Sex: Female · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Universitätsklinikum Erlangen, Strahlenklinik Coordinator of this site? Confirm its status | Erlangen | Germany | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.